Century Therapeutics (IPSC) Cash from Operations (QoQ) (2020 - 2026)
Century Therapeutics (IPSC) Cash from Operations (QoQ) (2020 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - |
| 10 | Century Therapeutics | 419.84 Mn | 285.04 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -56.90% |
| Dec 31, 2025 | 37.07% |
| Sep 30, 2025 | 7.28% |
| Jun 30, 2025 | 20.31% |
| Mar 31, 2025 | -42.93% |
| Dec 31, 2024 | 14.50% |
| Sep 30, 2024 | -3.66% |
| Jun 30, 2024 | 9.64% |
| Mar 31, 2024 | -15.32% |
| Dec 31, 2023 | -92.18% |
| Sep 30, 2023 | 29.10% |
| Jun 30, 2023 | 34.12% |
| Mar 31, 2023 | -27.55% |
| Dec 31, 2022 | 5.49% |
| Sep 30, 2022 | 5.16% |
| Jun 30, 2022 | -129.46% |
| Mar 31, 2022 | 456.26% |
| Dec 31, 2021 | -1.53% |
| Sep 30, 2021 | -29.71% |
| Jun 30, 2021 | 16.64% |